✨ Fisheries and Health Notices




26 APRIL

NEW ZEALAND GAZETTE

953

Product Name:
Thrane & Thrane Inmarsat-C Mobile Earth Station transceiver

Manufacturer:
Thrane & Thrane A/S Denmark

Model No.:
TT3022D

Software Version No.:
Capsat Version 3.24 Non-SOLAS Fishery, which is comprised of the following:

  • DTE Version: Capsat Version 3.03 (97-11-01)
  • DTE Forms: MAF FORMS
  • DCE Version: Capsat Version 3.24 (Jun 18 1999)
  1. Grant of type approvalβ€”Pursuant to regulation 5 (3) of the Fisheries (Satellite Vessel Monitoring) Regulations 1993, a provisional type approval has been granted to the following Inmarsat-C device to 30 September 2001:

Product Name:
Sailor Inmarsat-C Mobile Earth Station transceiver

Manufacturer:
Thrane & Thrane A/S Denmark

Model No.:
H1622D

Software Version No.:
Capsat Version 3.24 Non-SOLAS Fishery, which is comprised of the following:

  • DTE Version: Capsat Version 3.03 (97-11-01)
  • DTE Forms: MAF FORMS
  • DCE Version: Capsat Version 3.24 (Jun 18 1999)

Dated at Wellington this 24th day of April 2001.

D. J. WOOD, National Manager Compliance. In exercise of delegated authority.

go2966


Health

Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Aspartate – Glutamate

Active Ingredient(s):
Monosodium glutamate 228mmol/L
Sodium aspartate 228mmol/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Biomed Limited

Manufacturer(s):
Biomed Limited, Pt Chevalier, Auckland

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 23rd day of April 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go2974

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Alpha-Amoxi

Active Ingredient(s):
Amoxycillin (trihydrate) 31.2854mg/mL equivalent to 25mg/mL anhydrous amoxycillin

Dosage Form:
Granules for oral suspension

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer(s):
Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India

Product:
Alpha-Amoxi

Active Ingredient(s):
Amoxycillin (trihydrate) 62.5708mg/mL equivalent to 50.0mg/mL anhydrous amoxicillin

Dosage Form:
Granules for oral suspension

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer(s):
Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India

Product:
Lovir

Active Ingredient(s):
Aciclovir 250mg

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Douglas Pharmaceuticals Limited

Manufacturer(s):
Biologici Italia Laboratoires Srl, Novate Milanese, Milan, Italy



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 43


Gazette.govt.nz PDF NZ Gazette 2001, No 43





✨ LLM interpretation of page content

🌾 Fisheries (Automatic Location Communicator) Notice 2001 (No. 1) (continued from previous page)

🌾 Primary Industries & Resources
24 April 2001
Fisheries, Satellite Vessel Monitoring, Automatic Location Communicator, Inmarsat-C, Type Approval
  • D. J. Wood, National Manager Compliance

πŸ₯ Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
23 April 2001
Medicines Act 1981, Provisional Consent, Aspartate-Glutamate, Solution for infusion
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
23 April 2001
Medicines Act 1981, Consent, Alpha-Amoxi, Lovir, Amoxycillin, Aciclovir
  • G. R. Boyd, Chief Advisor, Safety and Regulation